Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Healthlead Public Company Limited - Asset Resilience Ratio
Healthlead Public Company Limited (HL) has an Asset Resilience Ratio of 30.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Healthlead Public Company Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Healthlead Public Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 0% |
| Short-term Investments | ฿451.03 Million | 30.06% |
| Total Liquid Assets | ฿451.03 Million | 30.06% |
Asset Resilience Insights
- Very High Liquidity: Healthlead Public Company Limited maintains exceptional liquid asset reserves at 30.06% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Healthlead Public Company Limited Industry Peers by Asset Resilience Ratio
Compare Healthlead Public Company Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Healthlead Public Company Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Healthlead Public Company Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 23.21% | ฿347.95 Million | ฿1.50 Billion | +7.11pp |
| 2023-12-31 | 16.10% | ฿223.06 Million | ฿1.39 Billion | -23.26pp |
| 2022-12-31 | 39.36% | ฿506.97 Million | ฿1.29 Billion | -- |
| 2021-12-31 | 0.00% | ฿0.00 | ฿1.12 Billion | -- |
| 2020-12-31 | 0.83% | ฿3.32 Million | ฿398.20 Million | +0.39pp |
| 2019-12-31 | 0.44% | ฿1.30 Million | ฿296.60 Million | -- |